Owner Biotica Technology Limited

Inventors Gaisser, Sabine; Moss, Steven; Petkovic, Hrvoje; Gregory, Matthew Alan

Agent Davies Collison Cave

Pub. Number AU-B-2003246965

PCT Number PCT/GB03/03230

PCT Pub. Number WO2004/007709

Priority 0224922.5 25.10.02 GB; 0216509.0 16.07.02 GB

Filing date 16 July 2003

Wipo publication date 2 February 2004

Acceptance publication date 15 May 2008

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61K 31/436 (2006.01)

A61K 31/706 (2006.01)

A61P 31/10 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

C07D 493/18 (2006.01) Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system

C07D 498/18 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07H 15/04 (2006.01) Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals

C07K 14/36 (2006.01) Peptides having more than 20 amino acids

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 15/10 (2006.01) Mutation or genetic engineering - Processes for the isolation, preparation or purification of DNA or RNA

C12N 15/52 (2006.01) Mutation or genetic engineering - Genes encoding for enzymes or proenzymes

C12N 15/70 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for E. coli

C12N 15/76 (2006.01) Mutation or genetic engineering

C12P 17/18 (2006.01) Preparation of heterocyclic carbon compounds with only O, N, S, Se, or Te as ring hetero atoms - containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin

C12P 19/62 (2006.01) Preparation of compounds containing saccharide radicals

C12R 1/55 (2006.01)